Error loading player: No playable sources found

Technical Seminar Sponsored by ProteinSimple, a Bio-Techne brand

Date
September 29, 2020
This product is not available for individual purchase, but it is available as part of the following products:
Thumbnail for CE Pharm 2020
CE PHARM 2020: CE IN THE BIOTECHNOLOGY & PHARMACEUTICAL INDUSTRIES

A new class of therapeutics has emerged in recent years, in which the core genetic information of a diseased patient can be changed or replaced. This therapy, called gene therapy, harnesses not only leading-edge genetic manipulation tools (i.e. CRISPR/Cas9) but also innovative delivery mechanisms that include lipid nanoparticles and live viruses.

The research and development requirements for gene therapy candidates are not that different from other biotherapeutics. To fully characterize these complex molecules, you need analytical instrumentation that you can rely on to make informed, accurate decisions. You still need speed, accuracy, and flexibility to support both characterization and release requirements. In this technical seminar, we will discuss various capillary electrophoresis solutions that can be easily implemented along the development path to support gene therapy development.

Moderator

Speaker Image for Ed Chase
ProteinSimple, a Bio-Techne Brand

Speaker

Speaker Image for Christopher Heger
ProteinSimple, a Bio-Techne Brand

Related Products

Thumbnail for Evaluation of a New iCIEF-MS Platform for Biotherapeutic Charge Variant Analysis
Evaluation of a New iCIEF-MS Platform for Biotherapeutic Charge Variant Analysis
Imaged capillary isoelectric focusing (iCIEF) is widely used for protein charge heterogeneity analysis during development and manufacturing of biotherapeutic drugs…